ECSP088098A - Nuevos regímenes para anticonceptivos orales monofásicos - Google Patents

Nuevos regímenes para anticonceptivos orales monofásicos

Info

Publication number
ECSP088098A
ECSP088098A EC2008008098A ECSP088098A ECSP088098A EC SP088098 A ECSP088098 A EC SP088098A EC 2008008098 A EC2008008098 A EC 2008008098A EC SP088098 A ECSP088098 A EC SP088098A EC SP088098 A ECSP088098 A EC SP088098A
Authority
EC
Ecuador
Prior art keywords
single phase
oral contraceptives
phase oral
new regimes
regimes
Prior art date
Application number
EC2008008098A
Other languages
English (en)
Inventor
Victoria Jane Davis
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34940210&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP088098(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Organon Nv filed Critical Organon Nv
Publication of ECSP088098A publication Critical patent/ECSP088098A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Fertilizers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención provee nuevos regímenes para anticonceptivos orales monofásicos
EC2008008098A 2005-06-21 2008-01-11 Nuevos regímenes para anticonceptivos orales monofásicos ECSP088098A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05105484 2005-06-21

Publications (1)

Publication Number Publication Date
ECSP088098A true ECSP088098A (es) 2008-02-20

Family

ID=34940210

Family Applications (2)

Application Number Title Priority Date Filing Date
EC2008008098A ECSP088098A (es) 2005-06-21 2008-01-11 Nuevos regímenes para anticonceptivos orales monofásicos
EC2008008097A ECSP088097A (es) 2005-06-21 2008-01-11 Nuevos regímenes para dispositivos de administración controlada de fármacos para anticoncepción

Family Applications After (1)

Application Number Title Priority Date Filing Date
EC2008008097A ECSP088097A (es) 2005-06-21 2008-01-11 Nuevos regímenes para dispositivos de administración controlada de fármacos para anticoncepción

Country Status (18)

Country Link
US (1) US20080206310A1 (es)
EP (2) EP1898849A4 (es)
JP (1) JP2008543935A (es)
KR (2) KR20080023747A (es)
CN (1) CN101511336A (es)
AR (1) AR054144A1 (es)
AU (2) AU2006262546B2 (es)
BR (2) BRPI0612519A2 (es)
CA (2) CA2611813C (es)
EC (2) ECSP088098A (es)
MX (1) MX2007016233A (es)
NO (1) NO20076347L (es)
PE (1) PE20070344A1 (es)
RU (1) RU2008102074A (es)
TW (1) TW200727920A (es)
UA (1) UA95447C2 (es)
WO (2) WO2007001888A2 (es)
ZA (2) ZA200710865B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
CN101500583B (zh) * 2006-07-12 2012-05-23 控制治疗（苏格兰）有限公司 含克林霉素盐酸盐的药物递送聚合物
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
US8741329B2 (en) 2007-09-21 2014-06-03 Merck Sharp & Dohme B.V. Drug delivery system
WO2010042610A1 (en) * 2008-10-08 2010-04-15 Agile Therapeutics, Inc. Transdermal delivery
EP2343963B1 (en) 2008-10-08 2019-04-10 Agile Therapeutics, Inc. Transdermal delivery
CA2740005C (en) 2008-10-08 2016-11-01 Agile Therapeutics, Inc. Transdermal delivery
CA2756222A1 (en) 2009-03-27 2010-09-30 Agile Therapeutics, Inc. Transdermal delivery
AR081670A1 (es) 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
US10849857B2 (en) 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US9603860B2 (en) 2010-07-28 2017-03-28 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
US10596103B2 (en) 2013-12-11 2020-03-24 Merek Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
US10918515B2 (en) 2015-03-31 2021-02-16 Merck Sharp & Dohme B.V. Vaginal ring applicator
CN113365634A (zh) * 2018-12-11 2021-09-07 卢品公司 超低剂量雌激素组合的药物递送系统及其方法和用途
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
US4736849A (en) * 1983-12-19 1988-04-12 Leonard Walter G Calendar-oriented pill dispenser
US4596576A (en) * 1984-10-12 1986-06-24 Akzo N.V. Release system for two or more active substances
US5010055A (en) * 1986-06-24 1991-04-23 The General Hospital Corporation Use of EGF to reverse the contraceptive activity of MIS
US5185374A (en) * 1988-05-11 1993-02-09 K.K. Ueno Seiyaku Oyo Kenkyujo Use of 15-ketoprostaglandin E or F compounds for uterine contraction
DE4202636A1 (de) * 1992-01-30 1993-08-05 Foldenauer Willi Vorrichtung und verfahren zur kennzeichnung von daten des inhalts einer verpackung
MX9301121A (es) * 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US6479475B1 (en) * 1996-07-26 2002-11-12 Wyeth Oral contraceptive
IL123813A0 (en) * 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances
DE10045380A1 (de) * 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
US20020189141A1 (en) * 2001-06-14 2002-12-19 Kabushiki-Kaisha Musshu Calendar for administrating medicine as prescribed
US7017513B2 (en) * 2001-08-08 2006-03-28 Harry Giewercer Dosage reminder device and medication carton
WO2003082336A1 (en) * 2002-04-03 2003-10-09 Jencap Research Ltd. Female birth control method
TW200404552A (en) * 2002-05-30 2004-04-01 Akzo Nobel Nv Self administered contraception
DK1462107T3 (da) * 2003-03-28 2008-11-03 Pantarhei Bioscience Bv Fremgangsmåde til kvindelig kontraception og kit til anvendelse i en sådan fremgangsmåde
US20040222123A1 (en) * 2003-05-06 2004-11-11 Barr Laboratories, Inc. Kit for pharmaceuticals
US20050113350A1 (en) * 2003-11-26 2005-05-26 Bernd Duesterberg Extended use combination comprising estrogens and progestins
US20050149362A1 (en) * 2003-12-30 2005-07-07 Peterson Per A. System and method for visually presenting digital patient information for future drug use resulting from dosage alteration
US7381393B2 (en) * 2004-10-07 2008-06-03 The Regents Of The University Of California Process for sulfur removal suitable for treating high-pressure gas streams
US20060079491A1 (en) * 2004-10-08 2006-04-13 Andreas Sachse Method of female hormonal contraception using a fixed extended cycle hormonal preparation containing dienogest and ethinyl estradiol

Also Published As

Publication number Publication date
WO2007001888A2 (en) 2007-01-04
KR20080025168A (ko) 2008-03-19
CN101511336A (zh) 2009-08-19
TW200727920A (en) 2007-08-01
UA95447C2 (ru) 2011-08-10
MX2007016233A (es) 2008-03-10
BRPI0612519A2 (pt) 2016-09-13
EP1898849A2 (en) 2008-03-19
EP1906968A4 (en) 2013-04-10
EP1898849A4 (en) 2013-01-23
JP2008543935A (ja) 2008-12-04
ZA200710862B (en) 2009-05-27
NO20076347L (no) 2008-03-17
ECSP088097A (es) 2008-02-20
BRPI0612263A2 (pt) 2012-04-24
WO2006138503A8 (en) 2007-07-05
AU2006262546B2 (en) 2013-09-05
ZA200710865B (en) 2008-10-29
WO2006138503A3 (en) 2009-05-14
US20080206310A1 (en) 2008-08-28
CA2611813A1 (en) 2006-12-28
RU2008102074A (ru) 2009-07-27
WO2006138503A2 (en) 2006-12-28
KR20080023747A (ko) 2008-03-14
EP1906968A2 (en) 2008-04-09
WO2007001888A3 (en) 2007-05-10
AR054144A1 (es) 2007-06-06
CA2611779A1 (en) 2007-01-04
CA2611813C (en) 2013-10-15
AU2006259344A1 (en) 2006-12-28
AU2006262546A1 (en) 2007-01-04
PE20070344A1 (es) 2007-04-16

Similar Documents

Publication Publication Date Title
ECSP088098A (es) Nuevos regímenes para anticonceptivos orales monofásicos
CY1112511T1 (el) Κρυσταλλικη στερεα βαση ρασαγιλινης (rasagiline)
HN2006011218A (es) Composiciones de tigeciclina y métodos de preparación
ATE534357T1 (de) Kühlende lokale pflasterzubereitung
DE602005001107D1 (de) Techniken für Mikrokanalkühlung
EA200801414A1 (ru) Кальцилитические соединения
ATE515256T1 (de) Antiperspirans-zusammensetzungen
DE602004011962D1 (de) Armstütze für Operateur
ES1061945Y (es) Envase para productos de confiteria.
ES1060453Y (es) Elementos para expositor desmontable
ITMI20051971A1 (it) Procedimento per la preparazione di - modafinil
ITMI20052464A1 (it) Procedimento per la preparazi9one di norelgestromin norelgestromina
ITMI20030826A1 (it) Composizione farmaceutica contenente interferone per il
ES1058317Y (es) Kit para la fabricacion de balaustres.
ITMI20051287A1 (it) Intercapedine termoisolante per imballaggi
ES1056171Y (es) Sifon para bide.
ES1056737Y (es) Envolvente para caramelos.
ES1058030Y (es) Dispositivo para la colocacion de extensiones de cabello.
ES1056319Y (es) Caja-estuche para cigarros puros.
ES1056532Y (es) Astil para productos de confiteria.
ES1059186Y (es) Caseta para sanitarios publicos.
ES1059178Y (es) Protector-embellecedor para electrodomesticos.
ES1060470Y (es) Dispositivo para la union de barandas
ES1061385Y (es) "bandeja para servicio de comidas"
ES1057098Y (es) Cercado mejorado para cerramiento.